A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.
Turrini R, Merlo A, Martorelli D, Faè DA, Sommaggio R, Montagner IM, Barbieri V, Marin O, Zanovello P, Dolcetti R, Rosato A.
Turrini R, et al. Among authors: martorelli d.
Oncoimmunology. 2017 Mar 16;6(4):e1304338. doi: 10.1080/2162402X.2017.1304338. eCollection 2017.
Oncoimmunology. 2017.
PMID: 28507812
Free PMC article.